Gábor Tóth
Director/Board Member at International Centre For Genetic Engineering & Biotechnology
Profile
Gábor Tóth is currently a Member-Governors Board at the International Centre For Genetic Engineering & Biotechnology.
Previously, he worked as a Member-Supervisory Board at Chemical Works of Gedeon Richter Plc.
Gábor Tóth active positions
| Companies | Position | Start |
|---|---|---|
International Centre For Genetic Engineering & Biotechnology
 International Centre For Genetic Engineering & Biotechnology Miscellaneous Commercial ServicesCommercial Services The International Centre for Genetic Engineering and Biotechnology is a research organization based in Trieste, Italy. The Italian company offers resources, tools, and know-how to fight the SARS-CoV-2 virus that causes COVID-19 to its member states free of charge. Additionally, the private company promotes international cooperation in developing and applying peaceful uses of genetic engineering and biotechnology, particularly for developing countries. The company's objective is to be the world's leading intergovernmental organization for research, training, and technology transfer in the field of life sciences and biotechnology. The company was founded in 1983, and Lawrence Banks has been the CEO since 2019. | Director/Board Member | - |
Former positions of Gábor Tóth
| Companies | Position | End |
|---|---|---|
| GEDEON RICHTER | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| GEDEON RICHTER | Health Technology |
| Private companies | 1 |
|---|---|
International Centre For Genetic Engineering & Biotechnology
International Centre For Genetic Engineering & Biotechnology Miscellaneous Commercial ServicesCommercial Services The International Centre for Genetic Engineering and Biotechnology is a research organization based in Trieste, Italy. The Italian company offers resources, tools, and know-how to fight the SARS-CoV-2 virus that causes COVID-19 to its member states free of charge. Additionally, the private company promotes international cooperation in developing and applying peaceful uses of genetic engineering and biotechnology, particularly for developing countries. The company's objective is to be the world's leading intergovernmental organization for research, training, and technology transfer in the field of life sciences and biotechnology. The company was founded in 1983, and Lawrence Banks has been the CEO since 2019. | Commercial Services |
- Stock Market
- Insiders
- Gábor Tóth
